Literature DB >> 7748273

Activity and subcellular distribution of phosphatidate phosphohydrolase (EC 3.1.3.4) in alcoholic liver disease.

K J Simpson1, S Venkatesan, A Martin, D N Brindley, T J Peters.   

Abstract

A micromethod was developed to assay the hepatic activity and subcellular distribution of phosphatidate phosphohydrolase (PAH, EC 3.1.3.4), an important regulatory enzyme in triacylglycerol synthesis, in human needle biopsy specimens. In normal liver PAH is predominantly cytosolic in distribution, but on treatment with oleic acid it shifts to the membranous compartments of the cell, its physiologically active site. The hepatic specific activity of PAH was similar in controls and patients with fatty liver but significantly more of the enzyme was associated with the membranous compartments in patients with severe alcoholic fatty liver. These observations may explain the enhanced rates of triacylglycerol synthesis observed in these patients and may be implicated in the pathogenesis of alcoholic fatty liver.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7748273

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  9 in total

1.  Regulation of hepatic lipin-1 by ethanol: role of AMP-activated protein kinase/sterol regulatory element-binding protein 1 signaling in mice.

Authors:  Ming Hu; Fengming Wang; Xin Li; Christopher Q Rogers; Xiaomei Liang; Brian N Finck; Mayurranjan S Mitra; Ray Zhang; Dave A Mitchell; Min You
Journal:  Hepatology       Date:  2011-12-29       Impact factor: 17.425

Review 2.  Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1.

Authors:  Min You; Alvin Jogasuria; Kwangwon Lee; Jiashin Wu; Yanqiao Zhang; Yoon Kwang Lee; Prabodh Sadana
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

Review 3.  Sirtuin 1 signaling and alcoholic fatty liver disease.

Authors:  Min You; Alvin Jogasuria; Charles Taylor; Jiashin Wu
Journal:  Hepatobiliary Surg Nutr       Date:  2015-04       Impact factor: 7.293

Review 4.  Effect of ethanol on lipid metabolism.

Authors:  Min You; Gavin E Arteel
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

5.  Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice.

Authors:  Zheng Shen; Xiaomei Liang; Christopher Q Rogers; Drew Rideout; Min You
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-12-10       Impact factor: 4.052

6.  Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.

Authors:  Huquan Yin; Ming Hu; Xiaomei Liang; Joanne M Ajmo; Xiaoling Li; Ramon Bataller; Gemma Odena; Stanley M Stevens; Min You
Journal:  Gastroenterology       Date:  2013-11-18       Impact factor: 22.682

7.  Glucocorticoids and cyclic AMP selectively increase hepatic lipin-1 expression, and insulin acts antagonistically.

Authors:  Boripont Manmontri; Meltem Sariahmetoglu; Jimmy Donkor; Maroun Bou Khalil; Meenakshi Sundaram; Zemin Yao; Karen Reue; Richard Lehner; David N Brindley
Journal:  J Lipid Res       Date:  2008-02-02       Impact factor: 5.922

8.  Hepatic-specific lipin-1 deficiency exacerbates experimental alcohol-induced steatohepatitis in mice.

Authors:  Ming Hu; Huquan Yin; Mayurranjan S Mitra; Xiaomei Liang; Joanne M Ajmo; Karim Nadra; Roman Chrast; Brian N Finck; Min You
Journal:  Hepatology       Date:  2013-10-17       Impact factor: 17.425

9.  Myeloid Cell-Specific Lipin-1 Deficiency Stimulates Endocrine Adiponectin-FGF15 Axis and Ameliorates Ethanol-Induced Liver Injury in Mice.

Authors:  Jiayou Wang; Chunki Kim; Alvin Jogasuria; Yoonhee Han; Xudong Hu; Jiashin Wu; Hong Shen; Roman Chrast; Brian N Finck; Min You
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.